FR2624015B1 - MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED - Google Patents

MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Info

Publication number
FR2624015B1
FR2624015B1 FR8716766A FR8716766A FR2624015B1 FR 2624015 B1 FR2624015 B1 FR 2624015B1 FR 8716766 A FR8716766 A FR 8716766A FR 8716766 A FR8716766 A FR 8716766A FR 2624015 B1 FR2624015 B1 FR 2624015B1
Authority
FR
France
Prior art keywords
colistine
tobramycin
amphotericin
vaporized
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8716766A
Other languages
French (fr)
Other versions
FR2624015A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medipro
Original Assignee
Medipro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipro filed Critical Medipro
Priority to FR8716766A priority Critical patent/FR2624015B1/en
Priority to AU27916/89A priority patent/AU2791689A/en
Priority to PCT/FR1988/000593 priority patent/WO1989005139A1/en
Priority to EP19890900266 priority patent/EP0390832A1/en
Publication of FR2624015A1 publication Critical patent/FR2624015A1/en
Application granted granted Critical
Publication of FR2624015B1 publication Critical patent/FR2624015B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8716766A 1987-12-03 1987-12-03 MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED Expired - Lifetime FR2624015B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8716766A FR2624015B1 (en) 1987-12-03 1987-12-03 MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
AU27916/89A AU2791689A (en) 1987-12-03 1988-12-05 Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization
PCT/FR1988/000593 WO1989005139A1 (en) 1987-12-03 1988-12-05 Medicinal preparation comprising the association of colistin, tobramycin and amphotericin b administered by atomization
EP19890900266 EP0390832A1 (en) 1987-12-03 1988-12-05 Medicinal preparation comprising the association of colistin, tobramycin and amphotericin b administered by atomization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716766A FR2624015B1 (en) 1987-12-03 1987-12-03 MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Publications (2)

Publication Number Publication Date
FR2624015A1 FR2624015A1 (en) 1989-06-09
FR2624015B1 true FR2624015B1 (en) 1990-06-29

Family

ID=9357419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8716766A Expired - Lifetime FR2624015B1 (en) 1987-12-03 1987-12-03 MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED

Country Status (4)

Country Link
EP (1) EP0390832A1 (en)
AU (1) AU2791689A (en)
FR (1) FR2624015B1 (en)
WO (1) WO1989005139A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2194049A1 (en) * 1994-06-28 1996-01-11 Georgi Stankov Novel clinical uses of polyene macrolides
DE4440391C1 (en) * 1994-11-11 1996-05-09 Haider Angelika Use of aminoglycosides for the diagnosis of barrier disorders
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (en) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizer
UA121114C2 (en) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Nebulizer, indicator device and container
ES2874029T3 (en) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizer
ES2954961T3 (en) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unit, nebulizer and method

Also Published As

Publication number Publication date
EP0390832A1 (en) 1990-10-10
FR2624015A1 (en) 1989-06-09
AU2791689A (en) 1989-07-05
WO1989005139A1 (en) 1989-06-15

Similar Documents

Publication Publication Date Title
FR2624015B1 (en) MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR2621817B1 (en) DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR2621818B1 (en) MEDICINE COMPRISING THE COMBINATION OF POLYMIXIN B, NETILMICIN AND AMPHOTERICIN B BY VAPORIZATION
NO951592D0 (en) Process for the preparation of a transdermal therapeutic system
DE69021387T2 (en) MEDICAL AEROSOL FORMULATIONS.
HK1026378A1 (en) Syringe serving also as an ampoule and syringe forcollecting blood.
DE68924540T2 (en) Medical aerosol formulations.
OA09194A (en) "Insecticidal treatment and compositions therefor".
DE68902300T2 (en) PHARMACEUTICAL SOLUTION CONTAINING SALBUTAMOL AND CROMOGLYCIN ACID.
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
NO167146C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CONDENSED DIAZEPINONES.
DE3867086D1 (en) BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL EFFECTS.
CA2091134A1 (en) Therapeutic agent for threatened abortion
NO881768L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES.
Buckles Cattle, corn and conflict in the Mexican tropics.
IL85869A (en) 14,15-dihydro-14,15-methylenemilbemycin derivatives,their preparation and their use as parasiticides and insecticides
NO166642C (en) ANAOLOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-ARYL-5-ALKYLTHIO-4H-1,2,4-TRIAZOLES.
NO903939L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CONDENSED DIAZEPINONES.
FR2694292B1 (en) Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments.
FR2697253B1 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
FR2657258B1 (en)
Greer Effects of NaCl on tobacco callus cultures
IL85449A (en) 26,27-mono-and 14,15:26,27-diepoxide 23-deoxy-ll-f28249 derivatives and parasiticidal use
FR2693194B1 (en) Alkanecarboxamide derivatives, their preparation and their therapeutic application.

Legal Events

Date Code Title Description
ST Notification of lapse